EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Breast Cancer, Version 4.2026, NCCN Clinical Practice Guidelines In Oncology

William J. Gradishar, Meena S. Moran, Jame Abraham, Vandana Abramson, Rebecca Aft, Doreen Agnese, Kimberly H. Allison, Bethany Anderson, Janet Bailey, Harold J. Burstein, Nan Chen, Helen Chew, Chau Dang, Anthony D. Elias, Sharon H. Giordano, Matthew P. Goetz, Rachel C. Jankowitz, Sara H. Javid, A. Marilyn Leitch, Janice Lyons, Susie McCloskey, Melissa McShane, Sameer A. Patel, Laura H. Rosenberger, Hope S. Rugo, Cesar A. Santa-Maria, Bryan P. Schneider, Mary Lou Smith, Hatem Soliman, Corey Speers, Melinda L. Telli, Mei Wei, Kari B. Wisinski, Amulya Yellala, Kay T. Yeung, Jessica S. Young, Ryan Schonfeld, Rashmi Kumar

Journal of the National Comprehensive Cancer Network · 2026-07 · 24 (7)

DOI: 10.6004/jnccn.2026.0033 ↗
AbstractBibliografische Angaben

Abstract

The NCCN Clinical Practice Guidelines for Breast Cancer include recommendations for clinical management of patients with carcinoma in situ, invasive breast cancer, Paget’s disease, Phyllodes tumor, inflammatory breast cancer, and management of breast cancer during pregnancy. The panel convenes annually to update recommendations based on a review of recently published clinical trials. This selection from the NCCN Guidelines for Breast Cancer focuses on the recommendations for the management of recurrent or stage IV (M1) metastatic breast cancer. It summarizes the treatment strategies stratified by tumor biology, including hormone receptor status and HER2 expression, as well as clinical factors such as prior therapy and disease-free interval. Throughout all treatment lines, supportive care, quality of life preservation, toxicity minimization, and clinical trial participation are emphasized as integral components of patient care.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →